logo

NUVB

Nuvation Bio
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

NUVB Profile

Nuvation Bio Inc.

A company that developing novel therapeutic candidates for the treatment of oncology

Pharmaceutical
04/24/2020
08/26/2020
New York Stock Exchange
220
12-31
Common stock
1500 Broadway, Suite 1401, New York, New York 10036
--
Nuvation Bio Inc. was incorporated in Delaware on April 24, 2020. The company is a biopharmaceutical company that addresses some of the largest unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's patented products include mechanistically different tumor treatment products, each targeting some of the most difficult cancer types to treat.